Shane Ward
CIK 1638380 · COO & CLO · last filed 2026-01-07
Shane Ward is a COO & CLO who has filed 29 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider disposed of $5.6M of CDTX on Jan 7, 2026. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
29
-$2.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) Delisted | COO & CLO | 0 | $221.38 | $0 | -$2.25M | 11 | 2026-01-07 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Sr VP and Chief Legal SO | 1,879 | $0.07 | $141 | $9.8K | 8 | 2020-06-02 |
| Aravive, Inc. (VSAR) Delisted | SVP and General Counsel | 201,556 | — | — | -$68.6K | 10 | 2018-02-12 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) Delisted | Disp (D) | −25,083 | -$5.56M | EDGAR |
| 2025-12-12 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | −15,041 | -$5.31M | EDGAR |
| 2025-04-02 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2025-03-13 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −1,664 | -$36.5K | EDGAR |
| 2024-10-02 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-20 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | +120,000 | $0 | EDGAR |
| 2024-03-12 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −20,473 | -$13.7K | EDGAR |
| 2023-03-29 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | +126,667 | $0 | EDGAR |
| 2023-03-13 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −4,329 | -$6.6K | EDGAR |
| 2022-04-04 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | +80,905 | -$19.2K | EDGAR |